BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33621436)

  • 1. Oral birch pollen immunotherapy with apples: Results of a phase II clinical pilot study.
    Nothegger B; Reider N; Covaciu CE; Cova V; Ahammer L; Eidelpes R; Unterhauser J; Platzgummer S; Raffeiner E; Tollinger M; Letschka T; Eisendle K
    Immun Inflamm Dis; 2021 Jun; 9(2):503-511. PubMed ID: 33621436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-specific immunotherapy with apples: selected cultivars could be a promising tool for birch pollen allergy.
    Nothegger B; Reider N; Covaciu CE; Cova V; Ahammer L; Eidelpes R; Unterhauser J; Platzgummer S; Tollinger M; Letschka T; Eisendle K
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1286-1292. PubMed ID: 31953891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy.
    Kopac P; Rudin M; Gentinetta T; Gerber R; Pichler Ch; Hausmann O; Schnyder B; Pichler WJ
    Allergy; 2012 Feb; 67(2):280-5. PubMed ID: 22070352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
    Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
    J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China.
    Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD
    J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients.
    Asero R
    Clin Exp Allergy; 1998 Nov; 28(11):1368-73. PubMed ID: 9824409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Birch Pollen Immunotherapy on Apple and rMal d 1 Challenges in Adults with Apple Allergy.
    van der Valk JPM; Nagl B; van Wljk RG; Bohle B; de Jong NW
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32085633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birch pollen immunotherapy inhibits anaphylaxis to the cross-reactive apple allergen Mal d 1 in mice.
    Utsch L; Logiantara A; Wallner M; Hofer H; van Ree R; van Rijt LS
    Clin Exp Allergy; 2016 Nov; 46(11):1474-1483. PubMed ID: 27376790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
    Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
    Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birch-apple syndrome treated with birch pollen immunotherapy.
    Mauro M; Russello M; Incorvaia C; Gazzola G; Frati F; Moingeon P; Passalacqua G
    Int Arch Allergy Immunol; 2011; 156(4):416-22. PubMed ID: 21832831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergy to apple cultivars among patients with birch pollinosis and oral allergy syndrome.
    Wagner A; Szwed A; Buczyłko K; Wagner W
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):399-404. PubMed ID: 27593099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food allergy to apple and specific immunotherapy with birch pollen.
    Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
    Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
    Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
    J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen immunotherapy for birch-apple syndrome: what do we know?
    Incorvaia C; Ridolo E; Mauro M; Russello M; Pastorello E
    Immunotherapy; 2017 Nov; 9(15):1271-1278. PubMed ID: 29130794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
    Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
    J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
    Cudowska B; Kaczmarski M; Restani P
    Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut.
    Bucher X; Pichler WJ; Dahinden CA; Helbling A
    Allergy; 2004 Dec; 59(12):1272-6. PubMed ID: 15507095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Incidence of Delayed-Type Hypersensitivity Reactions to Apples Among Patients Allergic to Birch Pollen.
    Wagner A; Zielińska-Bliźniewska H; Wagner W
    Allergy Asthma Immunol Res; 2018 Jul; 10(4):420-424. PubMed ID: 29949838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific-pollen immunotherapy in the treatment of oral allergy syndrome in patients with tree pollen hypersensitivity].
    Modrzyński M; Zawisza E; Rapiejko P; Przybylski G
    Przegl Lek; 2002; 59(12):1007-10. PubMed ID: 12731377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.